Insiders Biohit Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 10:44:09 2024-04-30 am EDT			5-day change	1st Jan Change
2.01 ^EUR	+0.50%		-0.50%	+6.63%

Apr. 15	Faron Pharmaceuticals reappoints former finance chief on interim basis	AN
Feb. 14	Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Faron Pharmaceuticals reappoints former finance chief on interim basis	Apr. 15	AN
Biohit Names New Chief Commercial Officer	Nov. 22	MT
Biohit Oyj Announces Changes in the Management Group	Nov. 22	CI
Biohit Oyj Elects Vesa Silaskivi as Chairman of the Board of Directors	23-06-15	CI
Biohit Oyj Approves Election of Vesa Silaskivi as Members of Board of Directors	23-06-14	CI
Biohit Oyj Announces Executive Changes	22-12-15	CI
Biohit Appoints New CFO	22-09-06	MT
Biohit Oyj Appoints Jussi Sorvo as Chief Financial Officer, Effective on September 7, 2022	22-09-06	CI
Biohit Oyj Appoints Jussi Sorvo as Member of the Management, Effective on September 7, 2022	22-09-06	CI
Finnish Biotech Biohit Appoints CFO as CEO	22-09-02	MT
Biohit Oyj Announces Executive Changes	22-09-02	CI
Biohit Oyj Appoints Lea Paloheimo as the Chairman of the Board of Directors	22-06-16	CI
Biohit Oyj Elects Kalle Härkönen as Board of Director	22-06-15	CI
Biohit Oyj Appoints MA Päivi Siltala as the CEO of the Company Starting September 1, 2021	21-07-29	CI
Biohit Oyj Elects Eero Lehti as the Chairman of the Board of Directors	21-06-29	CI
Biohit Oyj Announces Management Changes	21-06-28	CI
Biohit Oyj Appoints Jussi Hahtelala as Chief Financial Officer Starting June 4, 2021	21-05-24	CI
Biohit Oyj Appoints Jussi Hahtelala as Member of the Management Team Starting June 4, 2021	21-05-24	CI
Biohit Oyj's President and CEO Semi Korpela to Leave the Company	21-05-17	CI
Biohit Oyj's CEO Is on Sick Leave	21-03-26	CI

No results for this search